Navigation Links
Core Essence Secures $11.5 Million Series B Financing
Date:3/21/2011

FORT WASHINGTON, Pa., March 21, 2011 /PRNewswire/ -- Core Essence Orthopaedics, Inc. (Core Essence), a Fort Washington, Penn.-based orthopaedic device company, announced today it has raised $11.5 million in Series B financing. Baird Venture Partners led the round, joined by existing investor NewSpring Health Capital, Robin Hood Ventures and other individual investors. The funding, which follows a $5 million Series A round, will support the commercialization of the company's soft tissue and skeletal repair devices.

Core Essence has developed a range of products targeting high-volume, sports medicine procedures involving soft tissue and skeletal repair of the extremities. The company's products better enable surgeons to perform minimally invasive arthroscopic and endoscopic procedures, leading to higher success rates and lower recovery times.

"We are excited about establishing this partnership with Baird Venture Partners and the continued support we received from existing investors," said John Moran, CEO and Chairman of Core Essence. "There is increasingly strong demand for innovative solutions that maximize productivity and minimize complexity of existing surgical techniques. This financing will help us continue on the path toward meeting that demand."

"Core Essence is targeting two of the highest growth segments within the orthopaedic field today – extremities and sports medicine," said Pete Shagory, Partner at Baird Venture Partners. "Core Essence's novel product portfolio will enhance the ability of surgeons to meet the growing needs of their patients while providing them with the tools to achieve better outcomes."

"We are excited to continue to support Core Essence and very pleased to welcome Baird Venture Partners to the company," said Zev Scherl, a Core Essence Board member and a General Partner at NewSpring Capital.

As part of the transaction, Shagory will join Core Essence's Board of Directors.

About Core Essence Orthopaedics, Inc.

Core Essence Orthopaedics, Inc. (CE Ortho) is a privately held orthopaedic device company focused on the development, manufacturing and commercialization of solutions for minimally invasive soft tissue and arthroscopic musculoskeletal repair for the extremity market. CE Ortho's intuitive and innovative technologies are driven by increasing demands for alternatives to complicated surgical procedures. CE Ortho devices enable surgeons to build on classic and familiar surgical techniques with novel instruments and implants that simplify procedures and can be quickly mastered. The Company's proprietary technologies provide solutions to the growing volume of tendon and ligament repairs required by the active lifestyles of patients of all ages. For more company information, visit www.ceortho.com.  

About Baird Venture Partners

Baird Venture Partners, the U.S.-based venture capital fund of Baird Private Equity, makes venture capital investments in early and expansion stage business services and life sciences companies. Baird Venture Partners leverages its in-depth sector knowledge, experienced investment team and network of relationships to serve as a value-added partner for its portfolio companies.   For more information, please visit www.bairdventurepartners.com.

Baird Private Equity, the global private equity group of Robert W. Baird & Co. (Baird), makes venture capital, growth equity and buyout investments in smaller, high potential companies in the United States through Baird Venture Partners and Baird Capital Partners, in China through Baird Capital Partners Asia, and in Europe through Baird Capital Partners Europe.  Baird Private Equity has a global team of investment and operations professionals across the United States, Europe and Asia, including a team of operating professionals in Asia.  Baird Private Equity and its affiliates have raised and managed over $2.7 billion in capital and invested in more than 240 companies since the 1980s.  For more information, please visit www.bairdprivateequity.com.

About NewSpring Capital

NewSpring Capital, based in Radnor, Pennsylvania, Short Hills, New Jersey, Washington, D.C. and Baltimore, MD is a leading provider of private equity capital focused in the Mid-Atlantic region. NewSpring Capital currently has $600 million across three distinct investment strategies through its family of funds. For more information, please visit www.newspringcapital.com.


'/>"/>
SOURCE Core Essence Orthopaedics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CardioFocus Secures $5M Credit Facility with Silicon Valley Bank
2. Vystar® Corporation Secures a $3M Credit Facility to Fund Growth
3. Intuity Medical Secures $20M Credit Facility From Silicon Valley Bank and Oxford Finance Corporation
4. PLC Systems Secures $4 Million in Financing
5. Biomatrica Secures Strategic Investment from IQT
6. Digital Assent Secures $2 Million Series A Financing to Grow PatientPad Point-of-Care Network
7. TechniScan Secures $10 Million Equity Financing Facility
8. Poniard Pharmaceuticals Completes Voluntary Prepayment of Term Loans and Secures New Committed Equity Financing Facility
9. MedShape Solutions, Inc. Secures Investment From IQT to Support U.S. Intelligence Community
10. Audax Medical, Inc. Secures Exclusive Rights to Novel Osteobiologic Nanotechnology
11. Sutro Biopharma Secures $36.5 Million in Series C Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... SAN FRANCISCO , Feb. 11, 2016  Kindred ... focused on saving and improving the lives of pets, ... Technical Section of the New Animal Drug Application (NADA) ... the pivotal field study (KB0120) of Zimeta for the ... by the Company. --> ...
(Date:2/11/2016)... SAN FRANCISCO , Feb. 11, 2016   ... the advancement of new health technologies, announced today " ... outstanding achievements in health tech over the past ten ... For nearly a decade, Health 2.0 has served ... and showcased and connected with thousands of technologies, companies, ...
(Date:2/11/2016)... 11, 2016  MiMedx Group, Inc. (NASDAQ: MDXG ... membrane and other birth tissues, human skin and bone, ... market advanced products and therapies, announced today that it ... Healthcare Conference in New York , ... Michael J. Senken , Chief Financial Officer and ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... Dr. Sadati’s recent feature in ... Along with performing procedures, the magazine also highlights that Dr. Sadati has pioneered ... of the most common procedures he performs is his natural facelift. “As people ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... The president ... DoD Military Health System but would shift more of the cost burden to military ... TRICARE-reform plan laid out in the defense budget as including limited quantifiable benefit fixes ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... and women’s health, is pleased to announce the promotions of Allison Kelly to ... team, Steve Catone to executive vice president of North American capital sales, and ...
(Date:2/11/2016)... Laurel, NJ (PRWEB) , ... February 11, 2016 ... ... announces the call for nominations seeking candidates for the Board of Commissioners. Individuals ... with passion, skills and experience with diversity of clinical practice settings and across ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... of a master charity program created to assist the people of their local ... closely with nonprofit organizations and community leaders. Their hope is to bring awareness ...
Breaking Medicine News(10 mins):